What's the Rush? The Dissemination and Adoption of Preliminary Research Results
Open Access
- 15 March 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 98 (6), 372-373
- https://doi.org/10.1093/jnci/djj115
Abstract
How fast should the preliminary results of medical research be disseminated and adopted into clinical practice? In this issue of the Journal, Giordano et al. ( 1 ) provide an example of moving fast. They describe the substantial increase in use of taxane chemotherapy for women with node-positive breast cancer in the year following the presentation of the Cancer and Leukemia Group B (CALGB) 9344 study at the 1998 American Society of Clinical Oncology (ASCO) meeting—nearly 5 years before publication of the results in a peer-reviewed journal.Keywords
This publication has 5 references indexed in Scilit:
- Media reporting on research presented at scientific meetings: more caution neededThe Medical Journal of Australia, 2006
- Impact of a scientific presentation on community treatment patterns for primary breast cancer.JNCI Journal of the National Cancer Institute, 2006
- Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast CancerJournal of Clinical Oncology, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJama-Journal Of The American Medical Association, 2002
- Media Coverage of Scientific MeetingsJama-Journal Of The American Medical Association, 2002